Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 110901-110950 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03272932
Clinical Characteristics of Asthma and COPD Overlap for Patients With Asthma and COPD in Hong Kong
N/ARecruiting
1,600 participants
Started: Sep 15, 2017 · Completed: Dec 30, 2025
2 conditions1 sponsor1 location
NCT03058627
Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation
NAActive, not recruiting
454 participants
Started: Sep 15, 2017 · Completed: Nov 15, 2027
4 conditions14 sponsors12 locations
NCT03271190
Impact of a Cognitive Intervention Enriched With Leisure Activities in Persons With Subjective Cognitive Decline
NAActive, not recruiting
144 participants
Started: Sep 15, 2017 · Completed: Mar 31, 2025
1 condition3 sponsors2 locations
NCT03192020
Trial Comparing Treatment Strategies in Dupuytren's Contracture
PHASE4Active, not recruiting
302 participants
Started: Sep 15, 2017 · Completed: May 31, 2031
1 condition10 sponsors6 locations
NCT02255331
Using MRI To Detect Soft Tissue Reactions And Implant Integration As Related To Implant Modularity
N/ARecruiting
240 participants
Started: Sep 15, 2017 · Completed: Aug 31, 2026
2 conditions2 sponsors1 location
NCT03408353
Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study
N/ARecruiting
10,000 participants
Started: Sep 15, 2017 · Completed: Apr 30, 2027
1 condition2 sponsors1 location
NCT03323944
CAR T Cell Immunotherapy for Pancreatic Cancer
PHASE1Active, not recruiting
18 participants
Started: Sep 15, 2017 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT02999087
Randomized Trial of Avelumab-cetuximab-radiotherapy Versus SOCs in LA SCCHN (REACH)
PHASE3Active, not recruiting
707 participants
Started: Sep 14, 2017 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT03301792
Group Versus Traditional Prenatal Care for Diabetes
NAEnrolling by invitation
117 participants
Started: Sep 14, 2017 · Completed: Aug 31, 2025
3 conditions1 sponsor1 location
NCT06202976
Mapping Epileptic Networks Using Multimodal Imaging
N/ARecruiting
75 participants
Started: Sep 14, 2017 · Completed: Sep 13, 2033
1 condition1 sponsor1 location
NCT03202940
A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC
PHASE1/PHASE2Active, not recruiting
16 participants
Started: Sep 14, 2017 · Completed: Jan 1, 2031
1 condition2 sponsors1 location
NCT03503643
Hemi-Gland Cryoablation for Prostate Cancer at UCLA
N/AEnrolling by invitation
100 participants
Started: Sep 14, 2017 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT03253705
Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research
N/ARecruiting
1,000 participants
Started: Sep 14, 2017 · Completed: Aug 1, 2027
3 conditions1 sponsor1 location
NCT03569839
Modeling and Closed-loop Control of Depth of Anaesthesia
N/ARecruiting
50 participants
Started: Sep 14, 2017 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03213041
Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer
PHASE2Recruiting
100 participants
Started: Sep 14, 2017 · Completed: Jul 31, 2023
7 conditions3 sponsors1 location
NCT03193567
Study of High Efficient Killing Cell Therapy for Advanced NSCLC
PHASE1Recruiting
15 participants
Started: Sep 14, 2017 · Completed: May 1, 2025
1 condition2 sponsors1 location
NCT03230747
SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation
NAActive, not recruiting
72 participants
Started: Sep 14, 2017 · Completed: Aug 31, 2027
2 conditions1 sponsor9 locations
NCT03995199
A Comparison of Speech Outcome in Pediatric Cleft Patients, After Modified Furlow-Sommerlad Palatoplasty in Comparison to Modified Furlow Palatoplasty Alone
N/ARecruiting
60 participants
Started: Sep 13, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03581604
De-labeling of Patients With False Diagnosis of Penicillin Allergy
NARecruiting
200 participants
Started: Sep 13, 2017 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03241186
Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma
PHASE2Active, not recruiting
36 participants
Started: Sep 12, 2017 · Completed: Sep 30, 2023
1 condition3 sponsors7 locations
NCT03180268
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
PHASE3Recruiting
163 participants
Started: Sep 12, 2017 · Completed: Jun 15, 2027
2 conditions2 sponsors210 locations
NCT03457402
Shaping Tolerance for Delayed Rewards
NARecruiting
50 participants
Started: Sep 12, 2017 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT03193476
Registry for Patients With X-Linked Hypophosphatemia
N/ARecruiting
1,343 participants
Started: Sep 12, 2017 · Completed: Jul 1, 2029
1 condition2 sponsors118 locations
NCT04056377
Exercise, Arterial Modulation and Nutrition in Youth South Africa Study
N/AActive, not recruiting
1,065 participants
Started: Sep 12, 2017 · Completed: Dec 31, 2027
3 conditions3 sponsors1 location
NCT03216421
Intraoperative Radiation Therapy (IORT) in DCIS
NAActive, not recruiting
265 participants
Started: Sep 12, 2017 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT03282344
A Study of NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma
PHASE2Active, not recruiting
88 participants
Started: Sep 12, 2017 · Completed: Sep 30, 2026
1 condition4 sponsors2 locations
NCT03278509
Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)
PHASE4Active, not recruiting
5,000 participants
Started: Sep 11, 2017 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT03180996
Global Fenestrated Anaconda Clinical STudy
N/AActive, not recruiting
160 participants
Started: Sep 11, 2017 · Completed: Dec 31, 2030
1 condition1 sponsor11 locations
NCT03295682
Registry in Patients With Thoracoabdominal Aneurysms
N/AActive, not recruiting
47 participants
Started: Sep 11, 2017 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT04482972
Drug Coated Balloon Only vs Drug Eluting Stent Angioplasty
N/ARecruiting
10,000 participants
Started: Sep 11, 2017 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT03260023
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
PHASE1/PHASE2Active, not recruiting
150 participants
Started: Sep 11, 2017 · Completed: Dec 31, 2025
5 conditions4 sponsors20 locations
NCT03305835
Monogenic Kidney Stone - Genetic Testing
N/ARecruiting
6,000 participants
Started: Sep 11, 2017 · Completed: Feb 29, 2028
1 condition2 sponsors1 location
NCT03603210
Outcomes of Drug Coated Balloon Angioplasty, A UK Real Life Experience From 2009 to 2015
N/AActive, not recruiting
1,000 participants
Started: Sep 11, 2017 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT03238976
Nature Sounds as a Pain and Anxiety Reducing Strategy in Patients Undergoing Breast Core Biopsy
NAActive, not recruiting
200 participants
Started: Sep 11, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03162211
Feedback to Improve Depression Outcomes
NARecruiting
304 participants
Started: Sep 10, 2017 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT03025035
Pembrolizumab in Combination With Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancer
PHASE2Active, not recruiting
14 participants
Started: Sep 10, 2017 · Completed: Aug 8, 2026
1 condition2 sponsors1 location
NCT02910895
A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS)
NARecruiting
40 participants
Started: Sep 9, 2017 · Completed: Sep 30, 2024
3 conditions2 sponsors1 location
NCT03068624
Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma
PHASE1Active, not recruiting
34 participants
Started: Sep 8, 2017 · Completed: Jul 31, 2025
2 conditions2 sponsors1 location
NCT03700203
Cardiac Arrest Pursuit Trial with Unique Registration and Epidemiologic Surveillance
N/ARecruiting
5,340 participants
Started: Sep 7, 2017 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03223155
Concurrent or Sequential Immunotherapy and Radiation Therapy in Patients With Metastatic Lung Cancer
PHASE1Active, not recruiting
78 participants
Started: Sep 7, 2017 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT03245021
Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A
PHASE1Active, not recruiting
39 participants
Started: Sep 7, 2017 · Completed: Jun 30, 2027
1 condition2 sponsors5 locations
NCT03763864
Development of In Vitro Functional Assays From Primary Cells of Patients With Monogenic Diseases
NAEnrolling by invitation
100 participants
Started: Sep 6, 2017 · Completed: Sep 6, 2025
1 condition1 sponsor1 location
NCT03185026
Psychoeducation for Suicidal Behavior
NARecruiting
500 participants
Started: Sep 6, 2017 · Completed: May 6, 2026
2 conditions8 sponsors1 location
NCT03294759
Bio ACL Reconstruction Amnion Collagen Matrix Wrap and Stem Cells
NAActive, not recruiting
40 participants
Started: Sep 6, 2017 · Completed: Dec 6, 2024
1 condition2 sponsors1 location
NCT03735992
Mind-body Medicine for Patients With Malignant Hematological Diseases
NARecruiting
94 participants
Started: Sep 6, 2017 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT02979522
A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma
PHASE1/PHASE2Active, not recruiting
59 participants
Started: Sep 6, 2017 · Completed: Sep 24, 2029
1 condition1 sponsor14 locations
NCT05076396
PM14 Administered Intravenously to Patients with Advanced Solid Tumors
PHASE1Recruiting
150 participants
Started: Sep 6, 2017 · Completed: Aug 13, 2025
1 condition1 sponsor9 locations
NCT03210831
Early Predictors of Necrotizing Enterocolitis in Neonates
N/ARecruiting
450 participants
Started: Sep 6, 2017 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT02987686
Topical Infliximab for Sterile Corneal Melt
PHASE1Recruiting
12 participants
Started: Sep 6, 2017 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05547035
Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders
NARecruiting
200 participants
Started: Sep 5, 2017 · Completed: Jun 30, 2025
1 condition1 sponsor11 locations